Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis

Journal of NeuroVirology

Volumn 6, Issue 2, 2000, Pages 121-126

  Hara, Toshiro ^a   Yamashita, Sumimasa ^b   Aiba, Hideo ^c   Nihei, Kenji ^d   Koide, Nobuo ^e   Good, Robert A ^f   Takeshita, Kenzo ^g  

^a KYUSHU UNIVERSITY   (Japan)

^b Kanagawa Children's Hospital   (Japan)

^c SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^d NATIONAL CHILDREN S HOSPITAL   (Japan)

^e National Hospital Organization Iwaki Hospital   (Japan)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g TOTTORI UNIVERSITY   (Japan)

Author keywords

Interferon ; Interleukin 10; Interleukin 2; Prognosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MEASLES VIRUS; MUMPS VIRUS; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS; TH1 CELL; TH2 CELL; VARICELLA ZOSTER VIRUS;

HUMAN HERPESVIRUS 3; MEASLES VIRUS; MUMPS VIRUS; VARICELLA VIRUS;

EID: 0034028624     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009013155     Document Type: Article

References (26)

1. Allen IV, McQuaid S, McMahon J, Kirk J, McConnell R (1996). The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 55: 471-480.
2. Borrow P (1997). Mechanism of viral clearance and persistence. J Viral Hepatitis 4 (Suppl. 2): 16-24.
3. Brajczewska-Fischer W, Iwinska B, Kruszewska J, Koriak J, Czionkowska A (1989). Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing pan-encephalitis and exacerbation of multiple sclerosis. Acta Neurol Scand 80: 390-393.
4. Britt WJ (1998). Slow viruses. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD, (eds) WB Saunders: Tokyo, pp. 1646-1665.
5. Dhib-Jalbut S, McFarland HF, Mingioli ES, Sever JL, McFarlin DE (1988a). Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis. J Virol 62: 2483-2489.
6. Dhib-Jalbut S, Jacobson S, McFarlin DE, McFarland HF (1988b). Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann Neurol 25: 272-280.
7. Ewan PW, Lachmann PJ (1977). Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis. Clin Exp Immunol 30: 22-31.
8. Finke D, Brinckmann UG, ter Meulen V, Liebert UG (1995). Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 69: 5469-5474.
9. H2 immunity in neonatal mice. Science 271: 1728-1730.
10. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan M-C, Liu Y-J, Rabourdin-Combe C (1997). Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186: 813-823.
11. Gascon GG (1996). Subacute sclerosing panencephalitis. Semin Pediatr Neurol 3: 260-269.
12. Griffin DE, Ward BJ (1993). Differential CD4 T cell activation in measles. J Infect Dis 168: 275-281.
13. Griffin DE, Ward BJ, Esolen LM (1994). Pathogenesis of measles virus infection: An hypothesis for altered immune responses. J Infect Dis 170 (Suppl 1): 24-31.
14. Grosjean I, Caux C, Bella C, et al (1997). Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+T cells. J Exp Med 186: 801-812.
15. Hofman FM, Hinton DR, Baemayr J, Weil M, Merrill JE (1991) Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin Immunol Immunopathol 58: 331-342.
16. Karp CL, Wysocka M, Wahhl LM, et al (1996). Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228-231.
17. Nagano I, Nakamura S, Yoshioka M, Onodera J, Kogure K, Itoyama Y (1994). Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 44: 710-715.
18. Nakayama T, Urano T, Osano M, et al (1987). Interferon production by human peripheral lymphocytes in response to measles virus. Kitasato Arch Exp Med 60: 41-49.
19. Overall JC Jr (1998). Viral infections of the fetus and neonate. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD, (eds). WB Saunders: Tokyo, pp. 856-892.
20. Parra B, Hinton DR, Marten NW, et al (1999). IFN-γ is required for viral clearance from central nervous system oligodendroglia. J Immunol 162: 1641-1647.
21. Peterson JD, Karpus WJ, Clatch RJ, Miller SD (1993). Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 23: 46-55.
22. Ridge JP, Fuchs EJ, Matzinger P (1996). Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells. Science 271: 1723-1726.
23. Sarzotti M, Robbins DS, Hoffman PM (1996). Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271: 1726-1728.
24. Steel C, Guinea A, McCarthy JS, Ottesen EA (1994). Longterm effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet 343: 890-893.
25. Tsang M, Weatherbee J (1996). Quantitation of human IL-12 heterodimer and p40. Immunology Today 17: 213-214.
26. Zwiauer K, Forstenpointner E, Popow-Kraupp T, Hauser E, Jellinger KA (1995). Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection. Lancet 345: 1124.